Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Product Validation Study of 2 New Devices, EZ-NG (RightSpot pH Indicator) and EZ-pH (RightLevel pH Indicator)

NCT02065661 is registered in ClinicalTrials.gov with Florida Hospital Tampa Bay Division as lead sponsor.

NCT NCT02065661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02065661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Product Validation Study of 2 New Devices, EZ-NG (RightSpot pH Indicator) and EZ-pH (RightLevel pH Indicator)
Lead sponsor
Florida Hospital Tampa Bay Division
Phase
Observational
Overall status
Completed
Start date
September 30, 2011
Completion date
February 28, 2014
Enrollment
30 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bowel surgeries, colectomy, small bowel obstruction